December 31, 2025 · Form 4 insider transaction
Lind Kevin Robert bought 848 shares of Avalo Therapeutics, Inc. at $14.74 per share, a transaction worth $12.5K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 5 days after the transaction.
The options were granted on December 31, 2025, and are 100% vested.